SCHEMBL1346957

SCHEMBL1346957

CN1CCc2cc(O)cc3c2[C@H]1Cc1cccc(O)c1-3

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.77
DRD2 P14416 5/20 0.77
DRD1 P21728 4/20 0.77
ALDH1A1 P00352 5/20 0.74
MAPT P10636 4/20 0.74
CYP1A2 P05177 3/20 0.74
PKM P14618 3/20 0.74
MAPK1 P28482 3/20 0.74
HSD17B10 Q99714 3/20 0.74
NFKB1 P19838 2/20 0.74
THPO P40225 2/20 0.74
HIF1A Q16665 2/20 0.74
RGS12 O14924 1/20 0.74
MTOR P42345 1/20 0.74
GNAI1 P63096 1/20 0.74
KDM4E B2RXH2 3/20 0.72
HPGD P15428 3/20 0.72
KMT2A Q03164 3/20 0.72
LMNA P02545 2/20 0.72
GMNN O75496 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1346087 1.00 HTR1A (0.77) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL12877888 0.89 DRD2 (0.75) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL1346072 0.88 DRD2 (0.75) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL1347782 0.88 DRD2 (0.75) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL1348125 0.87 HTR1A (1.00) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL1348123 0.87 HTR1A (1.00) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL1204517 0.86 DRD1 (1.00) HTR1ADRD2DRD1DRD3HTR2A
SCHEMBL1204032 0.86 DRD1 (1.00) HTR1ADRD2DRD1DRD3HTR2A
Hydrochloric Acid SCHEMBL9468991 0.86 HTR1A (0.97) HTR1ADRD2DRD1ALDH1A1MAPT
SCHEMBL8344207 0.85 DRD2 (1.00) DRD2DRD1ALDH1A1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063060-B2 R(−)-11-hydroxyaporphine derivatives and uses thereof THE MCLEAN HOSPITAL CORPORATION (US) 2011-11-22 US disclosed
US-20100081651-A1 R(-)-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF THE MCLEAN HOSPITAL CORPORATION (US) 2010-04-01 US disclosed
US-7648995-B2 R(—)-11-hydroxyaporphine derivatives and uses thereof THE MCLEAN HOSPITAL CORPORATION (US) 2010-01-19 US disclosed
US-20060040900-A1 R(-)-11-hydroxyaporphine derivatives and uses thereof MCLEAN HOSPITAL CORPORATION, THE 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040900-A1 R(-)-11-hydroxyaporphine derivatives and uses thereof SNCA, HTR5A, PARK7 HTR1A 5/4885DRD2 23/4885DRD1 34/4885
US-20100081651-A1 R(-)-11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF SNCA, HTR5A, HTR3A HTR1A 5/4885DRD2 23/4885DRD1 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.